PB1935: MANAGEMENT OF NON-SEVERE APLASTIC ANEMIA: LABORATORY WORKUP AND TREATMENT PATTERNS.

PB1935: MANAGEMENT OF NON-SEVERE APLASTIC ANEMIA: LABORATORY WORKUP AND TREATMENT PATTERNS.

Bibliographic Details
Main Authors:	G. Cassanello, J. A. Giannotta, L. Cro, M. Barbieri, W. Barcellini, B. Fattizzo
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850580.84056.1d

Similar Items

Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk
by: Bruno Fattizzo, et al.
Published: (2020-07-01)

Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
by: Bruno Fattizzo, et al.
Published: (2020-06-01)

Infectious Complications in Autoimmune Hemolytic Anemia
by: Juri Alessandro Giannotta, et al.
Published: (2021-01-01)

Bortezomib in autoimmune hemolytic anemia and beyond
by: Raffaella Pasquale, et al.
Published: (2021-11-01)

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
by: Wilma Barcellini, et al.
Published: (2020-11-01)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
by: Bruno Fattizzo, et al.
Published: (2021-10-01)

PB1932: GENERIC ELTHROMBOPAG WITH STANDARD IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA
by: C. Ranjit Kumar, et al.
Published: (2022-06-01)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
by: Bruno Fattizzo, et al.
Published: (2020-11-01)

Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature
by: Marta Bortolotti, et al.
Published: (2022-03-01)

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
by: Bruno Fattizzo, et al.
Published: (2022-03-01)

The Changing Landscape of Autoimmune Hemolytic Anemia
by: Wilma Barcellini, et al.
Published: (2020-06-01)

PB2055: PREGNANCY IN PATIENTS WITH APLASTIC ANEMIA – CLINICAL OBSERVATIONS
by: Elene Shilova, et al.
Published: (2023-08-01)

APLASTIC ANEMIA
by: Ni Made Dharma Laksmi, et al.
Published: (2013-07-01)

Aplastic Anemia
by: Prasit Chanarat, et al.
Published: (2015-02-01)

OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY
by: Alfadil Haroon, et al.
Published: (2023-10-01)

Massive eosinophilia despite severe aplastic anemia
by: Aya Takahashi, et al.
Published: (2022-08-01)

Current management of severe acquired aplastic anemia
by: Phillip Scheinberg
Published: (2011-06-01)

COVID-19 in children with severe aplastic anemia
by: Dhwanee Thakkar, et al.
Published: (2022-09-01)

P1555: IRON CHELATION THERAPY IN CONGENITAL HEMOLYTIC ANEMIAS: AN ITALIAN SINGLE CENTER STUDY
by: A. Bosi, et al.
Published: (2022-06-01)

Diagnosis and Management of Autoimmune Hemolytic Anemias
by: Wilma Barcellini, et al.
Published: (2022-10-01)

Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
by: Bosi Alessandro, et al.
Published: (2022-08-01)

Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
by: Yawen Zhang, et al.
Published: (2023-07-01)

PB2037: NEW TERT VARIANT IN A FAMILY WITH APLASTIC ANEMIA
by: Marijana Virijevic, et al.
Published: (2023-08-01)

Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
by: Irene Motta, et al.
Published: (2021-08-01)

Aplastic anemia in pregnancy
by: Vijay Zutshi, et al.
Published: (2022-01-01)

Spontaneously resolved severe retinopathy associated with aplastic anemia
by: Washoo Mal, et al.
Published: (2021-01-01)

Role of eltrombopag in severe aplastic anemia treatment in children
by: Min-Yu Su, et al.
Published: (2021-11-01)

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
by: Juri Alessandro Giannotta, et al.
Published: (2021-11-01)

Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
by: Wilma Barcellini, et al.
Published: (2021-01-01)

Association of severe thrombocytopenia and poor prognosis in pregnancies with aplastic anemia.
by: Jae Eun Shin, et al.
Published: (2014-01-01)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
by: Li Ning, et al.
Published: (2012-10-01)

Very severe aplastic anemia in an 80‐year‐old man
by: Ganesh Kasinathan, et al.
Published: (2021-03-01)

Current evidence and the emerging role of eltrombopag in severe aplastic anemia
by: Beatrice Drexler, et al.
Published: (2021-03-01)

A College Athlete's Return from Severe Aplastic Anemia
by: Cole Miller, et al.
Published: (2019-05-01)

Idiopathic Aplastic Anemia: An Update
by: Elena E. Solomou
Published: (2019-03-01)

APLASTIC ANEMIA AND VIRAL HEPATITIS
by: Laura Cudillo
Published: (2009-11-01)

APLASTIC ANEMIA AND VIRAL HEPATITIS
by: Laura Cudillo
Published: (2009-11-01)

PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE
by: Nesrine Ben Sayed, et al.
Published: (2023-08-01)

PB2049: THE EFFICACY OF HETROMBOPAG PLUS CYCLOSPORINE A IN PATIENTS WITH TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY
by: Yuemin Gong, et al.
Published: (2023-08-01)

P1526: AUTOIMMUNE HEMOLYTIC ANEMIAS: RELATIONSHIP BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS OF CYTOKINE GENES AND CLINICAL/HEMATOLOGICAL PARAMETERS
by: A. Zaninoni, et al.
Published: (2022-06-01)